SCHEMBL4273197

SCHEMBL4273197

COc1ccc2oc3c(=O)[nH]c([C@@H]4C[C@H](F)CN4C(C)(C)C)nc3c2c1

nearest known ligand 0.65

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 17/20 0.65
CSNK2B P67870 17/20 0.65
CDC7 O00311 15/20 0.65
CSNK2A1 P68400 14/20 0.65
CSNK2A2 P19784 4/20 0.47
PIM3 Q86V86 3/20 0.47
PIM2 Q9P1W9 3/20 0.47
HRH4 Q9H3N8 2/20 0.42
CIT O14578 1/20 0.40
CYP1A2 P05177 1/20 0.40
GSK3B P49841 1/20 0.40
DYRK1A Q13627 1/20 0.40
CSNK2A3 Q8NEV1 1/20 0.40
TAOK3 Q9H2K8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4563578 1.00 PIM1 (0.65) PIM1CSNK2BCDC7CSNK2A1CSNK2A2
SCHEMBL4280461 0.87 PIM1 (0.62) PIM1CSNK2BCDC7CSNK2A1CSNK2A2
SCHEMBL1850649 0.85 PIM1 (0.59) PIM1CSNK2BCDC7CSNK2A1CSNK2A2
SCHEMBL1852448 0.85 PIM1 (0.59) PIM1CSNK2BCDC7CSNK2A1CSNK2A2
SCHEMBL1850651 0.85 PIM1 (0.59) PIM1CSNK2BCDC7CSNK2A1CSNK2A2
SCHEMBL4277139 0.83 PIM1 (0.56) PIM1CSNK2BCDC7CSNK2A1CSNK2A2
SCHEMBL1853925 0.79 CSNK2B (1.00) PIM1CSNK2BCDC7CSNK2A1CSNK2A2
SCHEMBL1852676 0.79 CSNK2B (1.00) PIM1CSNK2BCDC7CSNK2A1CSNK2A2
SCHEMBL4287795 0.76 PIM1 (0.55) PIM1CSNK2BCDC7CSNK2A1CSNK2A2
SCHEMBL1851020 0.75 PIM1 (0.59) PIM1CSNK2BCDC7CSNK2A1CSNK2A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2097419-A1 BENZOFUROPYRIMIDINONES AS PROTEIN KINASE INHIBITORS Exelixis, Inc. (US) 2009-09-09 EP disclosed
WO-2009086264-A1 BENZOFUROPYRIMIDINONES AS PROTEIN KINASE INHIBITORS EXELIXIS, INC. (US) 2009-07-09 WO disclosed